| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $468K | — | +38.8% |
| SG&A Expense | $574K | — | -69.0% |
| Net Income | -$991K | — | +54.5% |
| EPS (Basic) | -$0.03 | — | +57.1% |
| EPS (Diluted) | -$0.03 | — | +57.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.8M | -21.1% | +1078.7% |
| Total Assets | $5.8M | -21.1% | +1078.7% |
| Current Liabilities | $827K | -42.1% | +26.8% |
| Total Liabilities | $827K | -42.1% | +26.8% |
| Stockholders' Equity | $5.0M | -16.1% | +3180.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | -105.5% |
| Financing Cash Flow | $47K | — | — |